4-phenylbutylamine has been researched along with Canine Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; He, W; Hua, J; Li, B; Peng, S; Qin, D; Sun, J; Zhang, H | 1 |
1 trial(s) available for 4-phenylbutylamine and Canine Diseases
| Article | Year |
|---|---|
Immortalized canine adipose-derived mesenchymal stem cells alleviate gentamicin-induced acute kidney injury by inhibiting endoplasmic reticulum stress in mice and dogs.
Topics: Acute Kidney Injury; Animals; Apoptosis; Butylamines; Cells, Cultured; Culture Media; Dog Diseases; Dogs; Endoplasmic Reticulum Stress; Gentamicins; Kidney; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Phenylbutyrates | 2021 |